“It wasn’t until we were scheduling surgery to have it removed and I had an internal ultrasound that we realized that it was not an ovarian cyst; it was a 15-centimeter mass in my abdomen,” she says.
A non-Hodgkin’s lymphoma diagnosis
In June 2008, a CT scan confirmed that Kate had stage IV follicular monocleave cell lymphoma, a slow-progressing type of non-Hodgkin’s lymphoma.
“We were completely shocked, completely overwhelmed. It was like the whole world stopped,” she says.
Kate received eight rounds of chemotherapy at a hospital near her home in Mettawa, Illinois. She went into remission that November but relapsed three months later. Hoping to avoid the possibility of stem cell transplantation, she opted for radioimmunology treatment at a Chicago hospital. When that and an immunotherapy clinical trial didn’t work, her doctor told her that the only remaining option was an allogeneic stem cell transplant, which would use stem cells from a donor.
“It’s a world-class hospital, but when I was looking at the number of allogeneic stem cells they do a year, I just wasn’t comfortable,” she said.
Choosing MD Anderson for an allogeneic stem cell transplant
So her oncologist recommended she come to MD Anderson and meet with Richard Champlin, M.D., about her stem cell transplant.
“Dr. Champlin himself reached out to me. Normally a doctor has his APNs or nurses do the scheduling, so I was shocked when I answered the phone and it was him. And we spoke on the phone with him for an hour,” she says. “Before I even met Dr. Champlin, I just looked at my husband I said this is where I want to be.”
Four days later, Kate was in Houston for her first appointment.
“We were so amazed at the coordination between departments, the efficiency, the fact that my case had been discussed interdepartmentally,” she says. “We walked in and we got a full schedule. It was very thorough, and it was very obvious that every department that we talked to, they knew my case history.”
Kate returned home, and under the care of Dr. Champlin and her local oncologist, she began consolidation therapy to shrink the tumor.
Kate’s stem cell transplant
In June 2010, Kate and her husband left their two young children with their grandparents in Illinois and moved to Houston temporarily. Once her doctors had found an unrelated donor, Kate started chemotherapy to destroy the cancer and prepare her body for the transplant. She agreed to participate in a clinical trial in which Velcade was added to the pre-transplant chemo cocktail she’d been prescribed.
“I feel strongly that if we don’t participate in clinical trials, it’s going to take that much longer to find a cure,” she says.
Kate says the transplant itself was uneventful, but the aftermath was a different story.
“The week after the transplant was the hardest. Your white blood cell counts are at 0, you have no immune system, and all the cumulative effects of the chemo hits. It’s pretty miserable,” she says.
Life after a stem cell transplant
While things seemed to be improving for a while, Kate had a setback when she caught a cold in August 2010, and developed graft vs. host disease. Burton Dickey, M.D., prescribed Kate hypersteroids in hopes of healing her, but over time it became apparent that she’d suffered permanent lung damage. She spent the next few months in occupational and physical therapy and impressed doctors with her progress.
“I have absolutely blown the doors off what they could tell me I could do,” she says. “I did a 20-mile bike ride, and Dr. Dickey had told me that walking across the room would be difficult for me.”
Kate remains on medications to suppress her ongoing issues with graft vs. host disease. For her, though, that’s only a small price to pay for getting the opportunity to watch her children grow up.
“Despite everything, it’s been almost seven years since my transplant, and I can’t trade that for anything,” she says.